Urethra Carcinoma clinical trials at UC Health
1 in progress, 0 open to eligible people
Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma
Sorry, currently not accepting new patients, but might later
The purpose of the ATLAS study is to determine how patients with locally advanced unresectable or metastatic urothelial carcinoma respond to treatment with rucaparib.
at UCLA UCSD
Last updated: